Dr. Rosalia Viterbo
Dr. Rosalia Viterbo
I specialize in
I have been in practice
My answers and insights have
Helped 70 people
Received 1 doctor agrees
Here are kind words from others
This Thanksgiving, I wanted to share my appreciation for all that you do! Thank you, doctor! :)
I am located at
333 Cottman Avenue
Philadelphia , PA 19111
Philadelphia , PA 19111
Accepted Insurance Plans
I was educated and trained at
Medical / Graduate School
University at Buffalo, The State University of New York School of Medicine & Biomedical Sciences
Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy.
J. Urol., Jan;189(1):43-7 (2013)
Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses.
Can J Urol., Oct;19(5):6417-22 (2012)
Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors.
Urology., Aug;80(2):286-91 (2012)
Thermal ablation of the small renal mass: Case selection using the R.E.N.A.L-Nephrometry Score.
Urol. Oncol., Apr (2012)
Perioperative outcomes of robotic and open partial nephrectomy for moderately and highly complex renal lesions.
J. Urol., Jun;187(6):2000-4 (2012)
Need for intraoperative ultrasound and surgical recommendation for partial nephrectomy: correlation with tumor imaging features and urologist practice patterns.
Ultrasound Q., Mar;28(1):21-7 (2012)
Partial nephrectomy for renal masses â‰¥ 7 cm: technical, oncological and functional outcomes.
BJU Int., May;109(10):1450-6 (2012)
Current status of robot-assisted partial nephrectomy.
Curr Urol Rep., Feb;13(1):24-37 (2012)
Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass.
Urology., Nov;78(5):1089-94 (2011)
Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis.
Cancer., Feb;118(4):997-1006 (2012)
Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer.
Cancer., Jul;117(13):2883-91 (2011)
Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy.
Eur. Urol., Oct;60(4):724-30 (2011)
Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score.
Eur. Urol., Aug;60(2):241-8 (2011)
Routine adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the adrenal gland is radiographically normal.
J. Urol., Apr;185(4):1198-203 (2011)
Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors.
Urology., Apr;77(4):781-5 (2011)
Percutaneous vs surgical cryoablation of the small renal mass: is efficacy compromised?
BJU Int., May;107(9):1376-80 (2011)
Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy.
Urology., Jan;77(1):160-5 (2011)
Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy.
BJU Int., Jan;107(1):58-62 (2011)
Robot-assisted partial nephrectomy: a large single-institutional experience.
Urology., Jun;75(6):1328-34 (2010)
Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy.
BJU Int., Jul;106(2):218-23 (2010)
Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance.
Cancer., Jul;115(13):2844-52 (2009)
Residual prostate cancer after radiotherapy: a study of radical cystoprostatectomy specimens.
Urology., Sep;72(3):654-8 (2008)
Delayed intervention of sporadic renal masses undergoing active surveillance.
Cancer., Mar;112(5):1051-7 (2008)
Prior abdominal surgery and radiation do not complicate the retroperitoneoscopic approach to the kidney or adrenal gland.
J. Urol., Aug;174(2):446-50 (2005)
Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy.
BJU Int., Apr;95(6):843-6 (2005)
Dr. Rosalia Viterbo F